Emergent BioSolutions to Participate in Investor Conferences

GAITHERSBURG, Md., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the following investor conferences:

• Three Part Advisors IDEAS Midwest Conference August 25-26, 2021 Pre-recorded presentation available on August 26; 1-on-1 meetings on August 26

• Wells Fargo 2021 Virtual Healthcare Conference September 9-10, 2021 Fireside chat on September 9 at 9:20 am ET; 1-on-1 meetings all day

• Morgan Stanley 19th Annual Global Healthcare Conference September 9-10 & 13-15, 2021 Fireside chat on September 9 at 3:30 pm ET; 1-on-1 meetings all day

• Baird’s 2021 Global Healthcare Conference September 14-15, 2021 Fireside chat on September 14 at 4:55 pm ET; 1-on-1 meetings all day

• Singular Research Compelling Values Webinar September 16, 2021 Company presentation schedule will be posted on website

• Cantor 2021 Virtual Global Healthcare Conference September 27-30, 2021 Fireside chat on September 27 at 4:00 pm ET; 1-on-1 meetings all day

For conferences where a presentation is planned, the company’s webcast presentation may include a discussion of the company's recent business developments as well as its financial results and guidance. The webcast will be available both live, if possible, and by replay, and will be accessible from the Emergent website.

About Emergent BioSolutionsEmergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Through our specialty products and contract development and manufacturing services, we are dedicated to providing solutions that address public health threats. Through social responsibility, we aim to build healthier and safer communities. We aspire to deliver peace of mind to our patients and customers so they can focus on what’s most important in their lives. In working together, we envision protecting or enhancing 1 billion lives by 2030. For more information, visit our website and follow us on LinkedIn, Twitter, and Instagram.

Investor Contact:Robert G. BurrowsVice President, Investor Relations240-631-3280[email protected]  

Media Contact:Matt HartwigDirector, Media Relations[email protected]

Source: Emergent BioSolutions

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
• The Asian American Foundation and Wong Fu Productions Launch 'The United States of Asian+America' to Uncover the AAPI Trailblazers and Stories that Changed America
• Integris Report Finds U.S. Manufacturers Facing Widespread Cyber Breaches as Smart Factory Adoption Accelerates